Bet v 1-specific high-affinity secretory immunoglobulin A in nasal fluid is protective against birch pollen allergy

被引：0
|
作者：
Huber, S. [1 ]
Lang, R. [2 ]
Asam, C. [1 ]
Ferreira, F. [1 ]
Hawranek, T. [2 ]
Gadermaier, G. [1 ]
机构：
[1] Univ Salzburg, Dept Biosci, Salzburg, Austria
[2] Paracelsus Med Univ Salzburg, Univ Hosp, Dept Dermatol & Allergol, Salzburg, Austria
来源：
ALLERGY | 2021年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
212
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [1] High-affinity Bet v 1-specific secretory IgA antibodies in nasal fluids protect against birch pollen allergy
    Huber, Sara
    Lang, Roland
    Asam, Claudia
    Ferreira, Fatima
    Hawranek, Thomas
    Gadermaier, Gabriele
    ALLERGY, 2021, 76 (07) : 2267 - 2270
  • [2] Functional analysis of birch pollen allergen Bet v 1-specific regulatory T cells
    Nagato, Toshihiro
    Kobayashi, Hiroya
    Yanai, Mitsuru
    Sato, Keisuke
    Aoki, Naoko
    Oikawa, Kensuke
    Kimura, Shoji
    Abe, Yusuke
    Celis, Esteban
    Harabuchi, Yasuaki
    Tateno, Masatoshi
    JOURNAL OF IMMUNOLOGY, 2007, 178 (02): : 1189 - 1198
  • [3] Development of Bet v 1-specific DNA aptamers for quality control of birch pollen extracts
    Bethanis, A.
    Ferreira, F.
    Aglas, L.
    ALLERGY, 2018, 73 : 75 - 75
  • [4] Characterisation of recombinant Bet v 1 as a candidate vaccine against birch pollen allergy
    Nony, E.
    Chabre, H.
    Lautrette, A.
    Lemoine, P.
    Couret, M.
    Bobinnec, Y.
    Didierlaurent, A.
    Batard, T.
    Moingeon, P.
    ALLERGY, 2008, 63 : 232 - 232
  • [5] Impact of specific immunotherapy and environmental birch pollen exposure on Bet v 1-specific humoral and cellular profiles in birch pollen allergics and healthy individuals
    Moebs, C.
    Slotosch, C.
    Loeffler, H.
    Hertl, M.
    Pfuetzner, W.
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (03) : 277 - 277
  • [6] Isolation of a high-affinity Bet v 1-specific IgG-derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments
    Gadermaier, E.
    Marth, K.
    Lupinek, C.
    Campana, R.
    Hofer, G.
    Blatt, K.
    Smiljkovic, D.
    Roder, U.
    Focke-Tejkl, M.
    Vrtala, S.
    Keller, W.
    Valent, P.
    Valenta, R.
    Flicker, S.
    ALLERGY, 2018, 73 (07) : 1425 - 1435
  • [7] Bet v 1-specific immune response in birch pollen allergic patients treated with sublingual immunotherapy
    Moebs, C.
    Ruge, K.
    Hertl, M.
    Pfuetzner, W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S4 - S4
  • [8] Recombinant Bet v 1 vaccine for treatment of allergy to birch pollen
    Gronlund, Hans
    Gafvelin, Guro
    HUMAN VACCINES, 2010, 6 (12): : 970 - 977
  • [9] Bet v 1-specific immune responses in specific immunotherapy-treated birch pollen allergic individuals during seasonal pollen exposure
    Moebs, C.
    Slotosch, C.
    Loeffler, H.
    Hertl, M.
    Pfuetzner, W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S4 - S4
  • [10] Recombinant birch allergens (Bet v 1 and Bet v 2) and the oral allergy syndrome in patients allergic to birch pollen
    De Amici, M
    Mosca, M
    Vignini, M
    Quaglini, S
    Moratti, R
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2003, 91 (05) : 490 - 492
12345